| 28 Apr, 09:33 pm | — | … | Piramal Pharma Ltd - 543635 - Results - Financial Year Ended March 31, 2026 | bse |
| 28 Apr, 09:29 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Apr, 09:27 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 28 Apr, 09:25 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding change in Registered Office of the company. | nse |
| 28 Apr, 09:25 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 28 Apr, 09:23 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 28 Apr, 09:23 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 28 Apr, 09:22 pm | — | … | Piramal Pharma Limited has informed the Exchange about Change in Company Secretary/Compliance Officer | nse |
| 28 Apr, 09:21 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding Appointment of Mr. Maneesh Sharma as Company Secretary & Compliance Officer of the company w.e.f. April 29, 2026. | nse |
| 28 Apr, 09:19 pm | — | … | Piramal Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 28 Apr, 09:17 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding a press release dated April 28, 2026, titled "Piramal Pharma Limited Announces Results for Q4 and Full-year FY26". | nse |
| 28 Apr, 09:15 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding Cessation of Ms. Pratibha Mishra as Company Secretary & Compliance Officer of the company w.e.f. April 29, 2026. | nse |
| 28 Apr, 09:12 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2026. | nse |
| 28 Apr, 09:09 pm | — | … | Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 17 Apr, 02:17 pm | — | … | Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Audited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Financial Year Ended 31St March, 2026 | bse |
| 13 Apr, 10:23 am | — | … | Successful closure of US FDA Inspection at Piramal Pharma s manufacturing facility located at Lexington, USA | nse |
| 06 Apr, 06:32 pm | — | … | Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Rating | nse |
| 01 Apr, 04:25 pm | — | … | Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Completion of acquisition of Kenalog®, a branded commercial injectable product | nse |
| 20 Mar, 08:28 pm | — | … | Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Ratings | nse |
| 02 Mar, 03:26 pm | — | … | Piramal Pharma Limited has informed the Exchange about Schedule of Analyst/Investor meet | nse |
| 24 Feb, 05:07 pm | — | … | Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 14 Feb, 01:09 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Revocation of closure direction for Company s Dahej site | nse |
| 14 Feb, 12:57 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 FDA inspection | nse |
| 11 Feb, 06:42 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 05 Feb, 11:19 pm | — | … | Press release dated February 05, 2026, titled Press Release -Collaboration of Piramal Critical Care Inc (PCCI) and Blue-Zone Technologies Ltd (Blue-Zone) to capture, collect and recycle waste anaesthetic gases. | nse |
| 05 Feb, 11:16 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Feb, 10:43 am | — | … | Piramal Pharma Limited has informed the Exchange regarding Mr. Subramanian Ramadorai cessation as an Independent Director of the Company with effect from 9th February, 2026. | nse |
| 05 Feb, 10:31 am | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 04 Feb, 10:15 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 30 Jan, 06:00 pm | — | … | Piramal Pharma Limited has informed the Exchange about Transcript | nse |
| 30 Jan, 05:57 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 29 Jan, 05:05 pm | — | … | Piramal Pharma Limited has informed the Exchange about Link of Recording | nse |
| 29 Jan, 04:52 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 29 Jan, 12:32 am | — | … | Piramal Pharma Limited has informed the Exchange regarding resignation of Ms. Tanya Sanish as Company Secretary & Compliance Officer of the Company w.e.f. February 20, 2026. | nse |
| 29 Jan, 12:30 am | — | … | Piramal Pharma Limited has informed the Exchange regarding appointment of Ms. Pratibha Mishra as Company Secretary & Compliance Officer of the Company w.e.f. February 21, 2026. | nse |
| 29 Jan, 12:29 am | — | … | Piramal Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 29 Jan, 12:28 am | — | … | Piramal Pharma Limited has informed the Exchange about Change in Company Secretary and Compliance Officer | nse |
| 29 Jan, 12:25 am | — | … | Piramal Pharma Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Piramal Pharma Limited Announces Results for Q3 and 9M FY26". | nse |
| 29 Jan, 12:22 am | — | … | Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 29 Jan, 12:16 am | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | bse |
| 29 Jan, 12:13 am | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 29 Jan, 12:11 am | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jan, 12:02 am | — | … | Changes in Senior Management Personnel ( SMP ) and Key Managerial Personnel ( KMP ) of the Company | nse |
| 29 Jan, 12:00 am | — | … | Piramal Pharma Ltd - 543635 - Results - Financial Results For The Quarter Ended December 31, 2025 | bse |
| 28 Jan, 11:58 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 28 Jan, 11:57 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Acquisition of Kenalog®, a branded commercial injectable product | nse |
| 28 Jan, 11:54 pm | — | … | Piramal Pharma Ltd - 543635 - Board Meeting Outcome for Outcome Of Board Meeting Dated January 28, 2026 | bse |
| 21 Jan, 04:46 pm | — | … | Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 16 Jan, 12:18 pm | — | … | Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31St December, 2025. | bse |
| 11 Dec, 08:07 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 FDA inspection | nse |